A carregar...
A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity (ADCC) employing NK or high affinity NK (haNK) cells in combination with cetuximab
OBJECTIVE: Chordoma is a rare bone tumor derived from the notochord, and is resistant to conventional therapies such as chemotherapy, radiotherapy, and targeting therapeutics. Expression of epidermal growth factor receptor (EGFR) in a large proportion of chordoma specimens indicates that chordoma ma...
Na minha lista:
| Publicado no: | J Neurosurg |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6459012/ https://ncbi.nlm.nih.gov/pubmed/28753113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2017.1.JNS162610 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|